eMedicine Specialties > Emergency Medicine > Environmental
Burns, Chemical: Treatment & Medication
Updated: Jan 10, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Treatment
Prehospital Care
Prompt wound irrigation is the most critical aspect in preventing the extent of dermal burns from exposure to caustic substances. Animal studies have shown that irrigation of both acid exposures and alkaline exposures within several minutes decreases the pH change in the skin and the extent of dermal injury. A burn center case series found that patients who received irrigation within 10 minutes had a 5-fold decrease in full-thickness injury and a 2-fold decrease in length of hospital stay.7
- Prevent contaminated irrigation solution from running onto unaffected skin.
- Remove contaminated clothes.
- Special situations
- If contamination with metallic lithium, sodium, potassium, or magnesium has occurred, irrigation with water can result in a chemical reaction that causes burns to worsen. In these situations, the area should be covered with mineral oil and the metallic pieces should be removed with forceps and placed in mineral oil. If forceps are not available, soak the area with mineral oil and cover it with gauze soaked in mineral oil.
- If contamination with white phosphorus has occurred, thoroughly irrigate the area with water then cover the area with water-soaked gauze. Keep the area moist at all times. The area can also be covered with petroleum jelly.
Emergency Department Care
The first priority in treatment is to ensure complete removal of the offending agent. Thorough decontamination is key. Adequate irrigation is difficult to define and depends on the amount of exposure and the agent involved. Using litmus paper to measure the pH of the affected area or the irrigating solution is helpful. Complete removal and neutralization of concentrated acids and alkalis may require several hours of irrigation. Tap water is adequate for irrigation. Low-pressure irrigation is desired; high pressures may exacerbate the tissue injury.7,8,9,10
- If a question of airway compromise exists, secure the airway.
- Large surface burns require the same fluid therapy as that for thermal burns. See Burns, Thermal.
- After initial decontamination, the full extent of the injury must be ascertained and the patient must be treated as a typical burn patient. Based on the degree of injury, ensure adequate fluid resuscitation and take precautions to prevent complications (eg, hypothermia, infection, rhabdomyolysis).
- Special situations
- Elemental metals: The elemental forms of lithium, potassium, sodium, and magnesium react with water. If these metals are thought to be on the skin of a patient, do not irrigate with water. The metallic pieces should be removed manually with forceps and placed in a container of mineral oil.
- White phosphorus: Keep the area immersed in water and manually remove any phosphorus particles seen. Visualization under a Wood lamp may aid in detection and removal of retained phosphorus particles.2
- Phenol: Polyethylene glycol 300 or 400 and isopropyl alcohol have been recommended for the removal of phenols and cresols. If skin damage has already occurred, isopropyl alcohol may be very irritating. Polyethylene glycol should be diluted with water to form a 50:50 ratio prior to using. One study showed polyethylene glycol no more efficacious than copious water irrigation for phenol exposures.11
- Vesicants: See CBRNE – Vesicants, Mustard: Hd, Hn1-3, H and CBRNE – Vesicants, Organic Arsenicals: L, ED, MD, PD, HL for emergency department care.
- Hydrofluoric acid burns
- These burns require special consideration. They should initially be treated as any other burn, with thorough irrigation. However, due to the penetrating power of the fluoride ion, specific neutralization procedures are indicated. Fluoride can be neutralized by either calcium or magnesium. For small superficial burns, topical calcium or magnesium gels can be applied. Deeper burns usually require subcutaneous injections of calcium gluconate. Hand burns can be difficult to manage; these burns can be treated with subcutaneous injections of calcium, intra-arterial calcium infusions, or intravenous infusions of magnesium. Keeping the hand warm and adequately treating pain will help to increase local circulation and the body's natural supply of calcium and magnesium.12
- No objective comparative studies on these different treatments are underway. Studies on animals demonstrated that intravenous magnesium is as effective or more effective than subcutaneous injections of calcium in treating local hydrofluoric acid burns. When local treatment of hydrofluoric acid burns is not possible, this treatment is safe and should be considered.13
- Ocular exposures
- The goal for decontamination should be to achieve a pH (of the eye wash) of at least 7.2, preferably 7.4.
- If pH paper is not available, an adequate guideline is decontamination with 1-2 L of irrigation fluid over 30-60 minutes. A Morgan lens is contaminated with recommended for irrigation. Use a topical anesthetic prior to use.
- Caustic ingestions
- Gastric emptying is contraindicated. Activated charcoal is not useful and may interfere with subsequent endoscopy. Dilution with milk or water is contraindicated if any degree of airway compromise is present. Milk may interfere with subsequent endoscopy. Water is benign. Some substances, such as drain cleaners containing sulfuric acid or sodium hydroxide, generate heat when diluted with water. Local areas of heat generation can be minimized by diluting with a moderate quantity of fluid (250-500 mL).14,15,16
- Do not attempt to neutralize the caustic agent. Neutralizing the caustic agent may generate excessive heat from the exothermic reaction of neutralization.
Consultations
- For severe dermal burns, consult a general surgeon or a burn service. Burns to the hands, face, or perineum may require the appropriate specialties.
- Ophthalmologic consultation is recommended for patients with ocular burns from acids or bases if there is any significant degree of corneal or scleral injury.
- Caustic ingestions may require multiple specialties, including gastroenterology, GI surgery, ENT, and pediatric surgery for children.
- Consult a psychiatrist for cases of attempted suicide.
Medication
Medications have a limited role in the treatment of most chemical burns. Topical antibiotic therapy is usually recommended for dermal and ocular burns. Calcium or magnesium salts are used for hydrofluoric acid burns. Pain medications are important for subsequent burn care.
Steroid therapy is controversial for caustic ingestions but may be helpful for treating upper airway inflammation. No evidence indicates that steroid therapy decreases incidence of stricture formation. Steroids may predispose the patient to infection and may mask signs of perforation. There has been some use of aloe products on mild burns; however, currently, no definitive information on their use for chemical burns is available.17,15
Nonsteroidal anti-inflammatory agents do provide some degree of pain relief for mild burns by inhibition of prostaglandin mediators. These have not been evaluated for chemical burns and should be avoided in all cases of GI burns from ingestions.
After decontamination is performed on patients with chemical burns affecting a significant portion of the body, administer standard IV fluid and narcotic therapy as used for thermal burns. For additional information, see the Burns, Thermal article.
Antibiotics
Topical and ophthalmic antibiotics are routinely used for dermal and ocular burns, respectively. The injured tissues lose many of their protective mechanisms and are at increased risk of infection.
Silver sulfadiazine (Silvadene)
Used topically for dermal burns and useful in the prevention of infections from second- or third-degree burns. Has bactericidal activity against many gram-positive and gram-negative bacteria, including yeast.
Adult
Apply qd/bid to a thickness of 1/16th inch; continually cover burned area; remove all previous medication before applying each new dose
Pediatric
<2 years: Do not administer
>2 years: Apply topically as in adults
Reduces effectiveness of proteolytic enzymes
Documented hypersensitivity
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Patients with G-6-PD deficiency and renal insufficiency
Erythromycin ophthalmic ointment 0.5% (E-Mycin)
Use prophylactically to prevent infections following ocular burns. Ointment has a very low incidence of allergic reactions. Other possible agents include polymyxin B, bacitracin, and ciprofloxacin solutions.
Adult
Apply to affected eye topically tid/qid
Pediatric
Apply as in adults
None reported
Documented hypersensitivity; viral, mycobacterial, and fungal infections of the eye; patients using steroid combinations after uncomplicated removal of a foreign body from the cornea
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Do not use topical antibiotics to treat ocular infections that may become systemic; prolonged or repeated antibiotic therapy may result in bacterial or fungal overgrowth of nonsusceptible organisms and may lead to a secondary infection (take appropriate measures if superinfection occurs)
Bacitracin, neomycin, and polymyxin B (Neosporin Topical)
Used topically for dermal burns and useful in prevention of infections from second- or third-degree burns. Has bactericidal activity against many gram-positive and gram-negative bacteria, including yeast. Preferable for face and visible areas.
Adult
Apply 1/16th-inch thickness bid/tid; continually cover burned area; remove all previous medication before applying each new dose
Pediatric
Apply as in adults
None reported
Documented hypersensitivity; epithelial herpes simplex keratitis, mycobacterial, and fungal infections
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Caution in treating extensive burns (>20% body surface area) because absorption of neomycin is possible and may cause nephrotoxicity and ototoxicity; prolonged use may result in overgrowth of nonsusceptible organisms
Analgesics
Pain control is essential to quality patient care. Analgesics ensure patient comfort and have sedating properties, which are beneficial for patients who have sustained injuries to the eye.
Morphine is recommended in the ED. For outpatient treatment, combinations of hydrocodone or oxycodone and acetaminophen are usually sufficient. Codeine is not recommended.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are most commonly used for the relief of mild to moderate pain. Although effects of NSAIDs in the treatment of pain tend to be patient specific, ibuprofen is usually the DOC for initial therapy. Other options include flurbiprofen, ketoprofen, and naproxen.
Morphine sulfate (Duramorph, Astramorph, MS Contin)
DOC for narcotic analgesia because of reliable and predictable effects, safety profile, and ease of reversibility with naloxone.
Morphine sulfate administered IV may be dosed in a number of ways and is commonly titrated until the desired effect is obtained.
During the ED treatment of the acute burn, use IV (preferred) or IM for moderate or severe pain.
Adult
5-10 mg IV as loading dose; followed by 4-6 mg IV q10-15min prn
Pediatric
0.05-0.2 mg/kg IV/IM q2-4h; may need to titrate as in adults
Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate adverse effects of morphine
Documented hypersensitivity; hypotension; respiratory depression; potentially compromised airway with uncertain rapid airway control; nausea; emesis; constipation; urinary retention
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate
Acetaminophen with oxycodone (Tylox, Percocet)
Drug combination indicated for the relief of moderate to severe pain. DOC for aspirin-hypersensitive patients.
Formulations of oxycodone/acetaminophen are available as follows:
Tylox-5/500
Percocet-5/325
Percocet-7.5/500
Percocet-10/650
Adult
1-2 tab or cap PO q4-6h prn pain
Products containing more than 500 mg of acetaminophen/tab should only be prescribed one tab per dose
Pediatric
0.05-0.15 mg/kg/dose oxycodone PO; not to exceed 5 mg/dose of oxycodone q4-6h prn
Phenothiazines may decrease analgesic effects of this medication; toxicity increases with coadministration of either CNS depressants or tricyclic antidepressants
Documented hypersensitivity
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Duration of action may increase in elderly persons; be aware of total daily dose of acetaminophen patient is receiving; do not exceed 4,000 mg/d of acetaminophen; higher doses may cause liver toxicity
Acetaminophen with hydrocodone (Vicodin, Lorcet, Lortab, Norco)
Drug combination for outpatient use and indicated for the relief of moderate-to-severe pain.
Formulations of hydrocodone/acetaminophen are available as follows: Vicodin-5/500, ES-7.5/750, HP-10/600 Lorcet-10/650, Plus-7.5/650 Lortab-2.5/500, 5/500, 7.5/500, 10/500 Norco-10/325.
Typical elixirs contain 2.5 mg hydrocodone and 167 mg/mL acetaminophen.
Adult
1-2 tab or cap PO q4-6h prn for pain
Products containing more than 500 mg of acetaminophen/tab should only be prescribed one tab per dose
Pediatric
0.3 mL/kg q4h provides 10 mg/kg of acetaminophen and 0.15 mg/kg of hydrocodone
0.5 mL/kg q4h provides 16 mg/kg of acetaminophen and 0.25 mg/kg of hydrocodone
Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or tricyclic antidepressants
Documented hypersensitivity; elevated intracranial pressure
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Withhold for drowsiness; hepatic toxicity may occur in overdose; use Norco or a product that does not contain acetaminophen in patients with a history of severe hepatic disease; may cause constipation and stomach upset; caution in severe renal or hepatic dysfunction
Ibuprofen (Ibuprin, Advil, Motrin)
Usually the DOC for the treatment of mild to moderate pain, if no contraindications exist.
Inhibits inflammatory reactions and pain by decreasing activity of the enzyme cyclooxygenase, resulting in the inhibition of prostaglandin synthesis.
Useful for outpatient oral use where nonsedating drugs are preferred. Also has the advantage of an anti-inflammatory effect.
Adult
400-600-800 mg PO, approximately 100 mg/h (eg, 400 mg PO q4h, 600 mg q6h)
Pediatric
5-10 mg/kg PO q4-6h
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy
Ketoprofen (Oruvail, Orudis, Actron)
Used for the relief of mild to moderate pain and inflammation.
Initially administer small dosages to patients with a small body size, the elderly, and those with renal or liver disease.
When administering this medication, doses higher than 75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe patient for response.
Adult
25-50 mg PO q6-8h prn; not to exceed 300 mg/d
Pediatric
<3 months: Not established
3 months to 14 years: 0.1–1 mg/kg PO q6-8h
>14 years: Administer as in adults
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy
Naproxen (Anaprox, Naprelan, Naprosyn)
Used for relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing activity of enzyme cyclooxygenase, resulting in a decrease of prostaglandin synthesis.
Adult
500 mg PO followed by 250 mg PO q6-8h; not to exceed 1.25 g/d
Pediatric
<2 years: Not established
>2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug
Decontaminants
These agents can help remove offending substances from the skin and minimize their caustic effects.
Polyethylene glycol
Used as an aid in removing phenol or cresols. Desired agent is PEG 400 mixed 50:50 in water. Most hospitals are not likely to have this product. If not available, use bowel-cleansing products containing PEG.
Adult
Use liberally to remove phenol or cresols; may need to wipe off with gauze soaked in PEG solution
Pediatric
Apply as in adults
None reported for this indication
Documented hypersensitivity to PEG
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Be cautious on large surface areas of denuded skin; may cause metabolic acidosis or hypocalcemia; phenol may also cause metabolic acidosis if large surface area is involved
More on Burns, Chemical |
| Overview: Burns, Chemical |
| Differential Diagnoses & Workup: Burns, Chemical |
Treatment & Medication: Burns, Chemical |
| Follow-up: Burns, Chemical |
| References |
| « Previous Page | Next Page » |
References
Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila). 2006;44(6-7):803-932. [Medline].
Barillo DJ, Cancio LC, Goodwin CW. Treatment of white phosphorus and other chemical burn injuries at one burn center over a 51-year period. Burns. Aug 2004;30(5):448-52. [Medline].
Mannan A, Ghani S, Clarke A, Butler PE. Cases of chemical assault worldwide: a literature review. Burns. Mar 2007;33(2):149-54. [Medline].
Maguina P, Shah-Khan M, An G, Hanumadass M. Chemical scalp burns after hair highlights. J Burn Care Res. Mar-Apr 2007;28(2):361-3. [Medline].
Ramasamy K, Gumaste VV. Corrosive ingestion in adults. J Clin Gastroenterol. Aug 2003;37(2):119-24. [Medline].
Gorman RL, Khin-Maung-Gyi MT, Klein-Schwartz W, et al. Initial symptoms as predictors of esophageal injury in alkaline corrosive ingestions. Am J Emerg Med. May 1992;10(3):189-94. [Medline].
Leonard LG, Scheulen JJ, Munster AM. Chemical burns: effect of prompt first aid. J Trauma. May 1982;22(5):420-3. [Medline].
Mozingo DW, Smith AA, McManus WF, et al. Chemical burns. J Trauma. May 1988;28(5):642-7. [Medline].
Yano K, Hata Y, Matsuka K. Experimental study on alkaline skin injuries--periodic changes in subcutaneous tissue pH and the effects exerted by washing. Burns. Aug 1993;19(4):320-3. [Medline].
Yano K, Hosokawa K, Kakibuchi M, et al. Effects of washing acid injuries to the skin with water: an experimental study using rats. Burns. Nov 1995;21(7):500-2. [Medline].
Lin TM, Lee SS, Lai CS, Lin SD. Phenol burn. Burns. Jun 2006;32(4):517-21. [Medline].
Bertolini JC. Hydrofluoric acid: a review of toxicity. J Emerg Med. Mar-Apr 1992;10(2):163-8. [Medline].
Cox RD, Osgood KA. Evaluation of intravenous magnesium sulfate for the treatment of hydrofluoric acid burns. J Toxicol Clin Toxicol. 1994;32(2):123-36. [Medline].
Friedman EM, Lovejoy FH. The emergency management of caustic ingestions. Emerg Med Clin North Am. Feb 1984;2(1):77-86. [Medline].
Salzman M, O'Malley RN. Updates on the evaluation and management of caustic exposures. Emerg Med Clin North Am. May 2007;25(2):459-76; abstract x. [Medline].
Howell JM. Alkaline ingestions. Ann Emerg Med. Jul 1986;15(7):820-5. [Medline].
Fulton JA, Hoffman RS. Steroids in second degree caustic burns of the esophagus: a systematic pooled analysis of fifty years of human data: 1956-2006. Clin Toxicol (Phila). May 2007;45(4):402-8. [Medline].
Further Reading
Keywords
acid burns, base burns, corrosive ingestion, caustic burn, caustic chemical burn, esophageal burn, sulfuric acid, nitric acid, hydrofluoric acid, hydrochloric acid, muriatic acid, phosphoric acid, acetic acid, formic acid, chloroacetic acid, monochloroacetic acid, dichloroacetic acid, trichloroacetic acid, phenol, cresol, sodium hydroxide, potassium hydroxide, calcium hydroxide, calcium oxide, lime, ammonia, phosphate, chlorate, white phosphorus, vesicants, chromate, potassium dichromate, chromic acid, peroxides, hydrogen peroxide, bleach, potassium permanganate
Treatment & Medication: Burns, Chemical